Cite
Otsuji K, Takai K, Nishigaki Y, et al. Efficacy and safety of cisplatin versus miriplatin in transcatheter arterial chemoembolization and transarterial infusion chemotherapy for hepatocellular carcinoma: A randomized controlled trial. Hepatol Res. 2014;45(5):514-22doi: 10.1111/hepr.12376.
Otsuji, K., Takai, K., Nishigaki, Y., Shimizu, S., Hayashi, H., Imai, K., Suzuki, Y., Hanai, T., Ideta, T., Miyazaki, T., Tomita, E., Shimizu, M., & Moriwaki, H. (2015). Efficacy and safety of cisplatin versus miriplatin in transcatheter arterial chemoembolization and transarterial infusion chemotherapy for hepatocellular carcinoma: A randomized controlled trial. Hepatology research : the official journal of the Japan Society of Hepatology, 45(5), 514-22. https://doi.org/10.1111/hepr.12376
Otsuji, Kentarou, et al. "Efficacy and safety of cisplatin versus miriplatin in transcatheter arterial chemoembolization and transarterial infusion chemotherapy for hepatocellular carcinoma: A randomized controlled trial." Hepatology research : the official journal of the Japan Society of Hepatology vol. 45,5 (2015): 514-22. doi: https://doi.org/10.1111/hepr.12376
Otsuji K, Takai K, Nishigaki Y, Shimizu S, Hayashi H, Imai K, Suzuki Y, Hanai T, Ideta T, Miyazaki T, Tomita E, Shimizu M, Moriwaki H. Efficacy and safety of cisplatin versus miriplatin in transcatheter arterial chemoembolization and transarterial infusion chemotherapy for hepatocellular carcinoma: A randomized controlled trial. Hepatol Res. 2015 May;45(5):514-22. doi: 10.1111/hepr.12376. Epub 2014 Jul 24. PMID: 24961745.
Copy
Download .nbib